No results for ‘’
Dr Lalchandani Labs Ltd
₹6.98
(0%)
Tue, 25 Aug 2026, 03:22 pm
Health Services
Medical/Nursing Services
24.5KDr Lalchandani Labs Ratios
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Dr Lalchandani Labs Ltd Ratios
The Dr Lalchandani Labs Ltd Ratios page provides a complete fundamental analysis of Dr Lalchandani Labs Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Dr Lalchandani Labs Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Dr Lalchandani Labs Ltd (NSE: , BSE: 541299) is currently trading at ₹6.98, with a market capitalization of ₹0. As a major player in the Health services sector and Medical/Nursing services industry, Dr Lalchandani Labs Ltd remains a key stock for fundamental analysis using Dr Lalchandani Labs Ltd Ratios.
Dr Lalchandani Labs Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Dr Lalchandani Labs Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Dr Lalchandani Labs Ltd Ratios.
Historically, the Dr Lalchandani Labs Ltd P/E ratio has shown strong fluctuations:
The decline in Dr Lalchandani Labs Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Dr Lalchandani Labs Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.
Historical P/B trend:
Dr Lalchandani Labs Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Dr Lalchandani Labs Ltd P/S ratio currently stands at 0, an important part of Dr Lalchandani Labs Ltd Ratios for revenue valuation.
Historical P/S ratio:
A stable or declining Dr Lalchandani Labs Ltd P/S ratio indicates cautious market sentiment.
Dr Lalchandani Labs Ltd Price to Cash Flow Ratio (P/CF)
The Dr Lalchandani Labs Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.
Historical Dr Lalchandani Labs Ltd Price to Cash Flow Ratio:
The declining Dr Lalchandani Labs Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Dr Lalchandani Labs Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Dr Lalchandani Labs Ltd EV currently stands at ₹0, representing the total company valuation including debt.
Historical EV trend:
Dr Lalchandani Labs Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Dr Lalchandani Labs Ltd EV/EBITDA ratio is currently 0, a key metric in Dr Lalchandani Labs Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
Stable Dr Lalchandani Labs Ltd EV/EBITDA indicates balanced valuation.
Dr Lalchandani Labs Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Dr Lalchandani Labs Ltd D/E ratio is currently 0, reflecting leverage and financial stability.
Historical D/E:
Dr Lalchandani Labs Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Dr Lalchandani Labs Ltd ROE currently stands at 0%, showing profitability and capital efficiency.
Historical ROE:
Declining ROE indicates pressure on profitability.
Dr Lalchandani Labs Ltd Ratios Analysis Summary
The Dr Lalchandani Labs Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Dr Lalchandani Labs Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Dr Lalchandani Labs Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.